AUA/SUFU Guideline on the Treatment of Overactive Bladder Allows Access to ReviTM System Earlier in Treatment Journey

New Guideline Now Includes Implantable Tibial NeuroModulation (iTNM) Transitions Away from Step Therapy Requirement PARK CITY, Utah, April 29, 2024 /PRNewswire/ — BlueWind Medical, Ltd., a pioneer in implantable Tibial NeuroModulation (iTNM) and the developer of ReviTM, a patient-centric…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks